Skip to main content
. 2014 Jun 25;14:213. doi: 10.1186/1471-2393-14-213

Table 1.

Maternal characteristics of non-smokers and smokers before pregnancy and of continuers and quitters during pregnancy

Maternal characteristics Total study sample (n = 8344)
Women smoking (n = 2944)
Women not smoking
Women smoking before pregnancy
p-value
Women who continued smoking when pregnant
Women who quit smoking when pregnant
p-value
(n = 5400) (64.7%)
(n = 2944) (35.3%)
 
(n = 771) (26.2%)
(n = 2173) (73.8%)
 
n (%) n (%)   n (%) n (%)  
Region of residency
 
 
 
 
 
 
Western Europe*
2240 (41.5)
954 (32.4)
<0.001
277 (35.9)
677 (31.2)
0.014
Northern Europe
1922 (35.6)
893 (30.3)
 
206 (26.7)
687 (31.6)
 
Eastern Europe§
1238 (22.9)
1097 (37.3)
 
288 (37.4)
809 (37.2)
 
Maternal age
 
 
 
 
 
 
≤ 20
95 (1.8)
151 (5.1)
<0.001
51 (6.6)
100 (4.6)
0.051
21-30
2802 (51.9)
1777 (60.4)
 
459 (59.5)
1318 (60.7)
 
31-40
2375 (44.0)
976 (33.2)
 
246 (31.9)
730 (33.6)
 
> 40
128 (2.4)
40 (1.4)
 
15 (1.9)
25 (1.2)
 
Marital status
 
 
 
 
 
 
Married/cohabiting
5232 (96.9)
2694 (91.5)
<0.001
668 (86.6)
2026 (93.2)
<0.001
Other
168 (3.1)
250 (8.5)
 
103 (13.4)
147 (6.8)
 
Highest education level
 
 
 
 
 
 
Less than high school
147 (2.7)
220 (7.5)
<0.001
95 (12.3)
125 (5.8)
<0.001
High school
1360 (25.2)
1014 (34.4)
 
348 (45.1)
666 (30.6)
 
More than high school
3260 (60.4)
1366 (46.4)
 
230 (29.8)
1136 (52.3)
 
Other
633 (11.7)
344 (11.7)
 
98 (12.7)
246 (11.3)
 
Health literacy**
 
 
 
 
 
 
Low
264 (5.0)
215 (7.4)
<0.001
74 (9.8)
141 (6.6)
0.015
Medium
2113 (39.7)
1372 (47.4)
 
349 (46.3)
1023 (47.8)
 
High
2943 (55.3)
1305 (45.1)
 
331 (43.9)
974 (45.6)
 
Working status
 
 
 
 
 
 
Employed (not as HCP)
3273 (60.7)
1755 (59.7)
<0.001
418 (54.4)
1337 (61.6)
<0.001
Healthcare personnel (HCP)
772 (14.3)
349 (11.9)
 
73 (9.5)
276 (12.7)
 
Housewife
449 (8.3)
208 (7.1)
 
82 (10.7)
126 (5.8)
 
Other
898 (16.7)
629 (21.4)
 
196 (25.5)
433 (19.9)
 
First language
 
 
 
 
 
 
Same as in country of residency
5071 (94.1)
2795 (95.2)
0.047
733 (95.3)
2062 (95.1)
0.894
Other
318 (5.9)
142 (4.8)
 
36 (4.7)
106 (4.9)
 
Previous children
 
 
 
 
 
 
No
2633 (48.8)
1617 (54.9)
<0.001
385 (49.9)
1232 (56.7)
0.001
Yes
2767 (51.2)
1327 (45.1)
 
386 (50.1)
941 (43.3)
 
Morbidity not incl. RD††
 
 
 
 
 
 
Yes
541 (18.4)
941 (17.4)
0.291
157 (20.4)
384 (17.7)
0.109
No
2403 (81.6)
4459 (82.6)
 
614 (79.6)
1789 (82.3)
 
Respiratory disease§§
 
 
 
 
 
 
Yes
306 (10.4)
603 (11.2)
0.296
71 (9.2)
235 (10.8)
0.235
No
2638 (89.6)
4797 (88.8)
 
700 (90.8)
1938 (89.2)
 
Planned pregnancy
 
 
 
 
 
 
Yes/not completely unexpected
5002 (93.0)
2606 (88.7)
<0.001
647 (84.0)
1959 (90.3)
<0.001
No, it was not planned
377 (7.0)
333 (11.3)
 
123 (16.0)
210 (9.7)
 
Folic acid use*†
 
 
 
 
 
 
Yes
5022 (93.5)
2600 (89.2)
<0.001
642 (84.9)
1958 (90.7)
<0.001
No
347 (6.5)
314 (10.8)
 
114 (15.1)
200 (9.3)
 
Alcohol consumption during pregnancy
 
 
 
 
 
 
Yes
790 (14.8)
527 (18.0)
<0.001
154 (20.1)
373 (17.3)
0.090
No 4556 (85.2) 2398 (82.0)   612 (79.9) 1786 (82.7)  

HCP = health care provider; RD = respiratory disease.

Numbers may not add up to total due to missing values. For Folic acid use and Alcohol consumption during pregnancy, the response ‘cannot remember’ was treated as a missing value. Missing values are less than 5% of the total.

*Includes Austria, France, Italy, Switzerland, the Netherlands, United Kingdom.

Includes Finland, Iceland, Norway, Sweden.

§Includes Croatia, Poland, Russia, Serbia, Slovenia.

**Measured by a self-assessment scale comprising three questions corresponding to the set of brief screening questions (SBSQ) developed to detect inadequate or marginal health literacy in clinical settings [26,27].

††Includes the presence of a chronic disease (hypothyroidism, rheumatic diseases (incl. rheumatoid arthritis, psoriatic arthritis), diabetes (type I or II), epilepsy, depression, anxiety, and cardiovascular diseases (incl. hypertension, high cholesterol, and heart diseases) or others (open-ended option)).

§§Includes the presence of asthma, allergy, rhinitis, tonsillitis, sinusitis, or other respiratory tract conditions.

*†Indicates folic acid use before and/or during pregnancy.